Live Breaking News & Updates on Mark Levis

Stay updated with breaking news from Mark levis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transcripts For KPIX KPIX 5 News At 6AM 20161007

In just a moment. But first marlie hall is in orlando. Marley . Reporter matthew is expected to come ashore or very close to it later today. The entire florida coast is bracing for a long day of punishing wind, rain and storm surge. You can feel the droplets hit your leg, hit your arm, hit your hands. Reporter Hurricane Matthew is making its presence felt across the florida coast. And this is only at half the wind speed that its supposed to be. Reporter overnight the outer bands of the storm gang pummeling the area with began pummeling the area with rain and winds. The category 3 storm sent boats rocking. Its quite a sight. Reporter storm shutters were ripped off the front of businesses in West Palm Beach. In Daytona Beach, police were left patrolling empty streets as most residents listened to evacuation warnings. We ....

United States , South Carolina , Mount Vaca , Wrigley Field , Central Valley , New York , Clayton Valley , San Diego , Pebble Beach , San Francisco , Noord Holland , San Francisco Bay , San Luis Obispo County , Monterey Bay , North Beach , South Shore , Altamont Pass , New Hampshire , San Leandro , Stanford University , Daytona Beach , Fort Lauderdale , Town Hall , Fort Mason , Marina Green , Carl Ferrer ,

Quizartinib May Represent an Additional Therapeutic Option for FLT3-ITD+ AML

Mark Levis, MD, PhD, discusses potential changes to the FLT3-ITD-mutated acute myeloid leukemia treatment landscape that may occur if the FDA approves quizartinib, key efficacy and safety data with the agent, and how quizartinib compares with midostaurin. ....

United States , Mark Levis , Hematologic Malignancies , Bone Marrow Transplant Program , Flt3 Itd Mutated Acute Myeloid Leukemia Treatment Landscape , Fda Approves Quizartinib , How Quizartinib Compares With Midostaurin , Quantumr Randomized Data , Ratify Trial ,